-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Adverum Biotechnologies, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
- Adverum Biotechnologies, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$29.2M, a 15.4% increase year-over-year.
- Adverum Biotechnologies, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$103M, a 21.8% increase year-over-year.
- Adverum Biotechnologies, Inc. annual Operating Income (Loss) for 2023 was -$124M, a 21.1% increase from 2022.
- Adverum Biotechnologies, Inc. annual Operating Income (Loss) for 2022 was -$157M, a 7.54% decline from 2021.
- Adverum Biotechnologies, Inc. annual Operating Income (Loss) for 2021 was -$146M, a 23.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)